Coronary flow reserve increase after 4-year dapagliflozin treatment in patients with type 2 diabetes: the DAPAHEART follow-up study - BioMed Central

Coronary flow reserve increase after 4-year dapagliflozin treatment in patients with type 2 diabetes: the DAPAHEART follow-up study  BioMed ...

Coronary,flow,reserve,increase,after,4-year,dapagliflozin,treatment,in,patients